MEDISTEP

Medistep Healthcare Share Price

 

 

Start SIP in MEDISTEP

Start SIP

Performance

  • Low
  • ₹23
  • High
  • ₹27
  • 52 Week Low
  • ₹22
  • 52 Week High
  • ₹53
  • Open Price₹27
  • Previous Close₹25
  • Volume36,000
  • 50 DMA₹26.81
  • 100 DMA-
  • 200 DMA-

Investment Returns

  • Over 1 Month -4.78%
  • Over 3 Month -19.79%
  • Over 6 Month -46.74%
  • Over 1 Year -46.74%

Smart Investing Starts Here Start SIP with Medistep Healthcare for Steady Growth!

Invest Now

Medistep Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 7.9
  • PEG Ratio
  • -
  • Market Cap Cr
  • 33
  • P/B Ratio
  • 0.9
  • Average True Range
  • 1.68
  • EPS
  • 2.92
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.38
  • RSI
  • 41.29
  • MFI
  • 53.2

Medistep Healthcare Financials

Medistep Healthcare Technicals

EMA & SMA

Current Price
₹22.90
-1.65 (-6.72%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 0
  • 20 Day
  • ₹25.23
  • 50 Day
  • ₹26.81
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

24.07 Pivot Speed
  • R3 29.93
  • R2 28.37
  • R1 25.63
  • S1 21.33
  • S2 19.77
  • S3 17.03

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Medistep Healthcare Limited manufactures sanitary pads, energy powder, and trades a wide range of pharmaceutical products. With a focus on quality, innovation, and customer service

Medistep Healthcare Ltd has an operating revenue of Rs. 137.57 Cr. on a trailing 12-month basis. An annual revenue growth of 57% is outstanding, Pre-tax margin of 11% is healthy, ROE of 24% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 48 which is a POOR score indicating inconsistency in earnings, a RS Rating of 8 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 79 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Medistep Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-11 Quarterly Results

Medistep Healthcare F&O

Medistep Healthcare Shareholding Pattern

68.96%
26.61%
4.43%

About Medistep Healthcare

  • NSE Symbol
  • MEDISTEP
  • BSE Symbol
  • Managing Director
  • Mr. Girdhari Lal Prajapat
  • ISIN
  • INE0UOY01019

Similar Stocks to Medistep Healthcare

Medistep Healthcare FAQs

Medistep Healthcare share price is ₹22 As on 21 January, 2026 | 03:29

The Market Cap of Medistep Healthcare is ₹32.5 Cr As on 21 January, 2026 | 03:29

The P/E ratio of Medistep Healthcare is 7.9 As on 21 January, 2026 | 03:29

The PB ratio of Medistep Healthcare is 0.9 As on 21 January, 2026 | 03:29

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23